Gendis Inc. Shares Purchased Under Normal Course Issuer Bid

Nov 5, 2008 4:12:00 PM

WINNIPEG, MANITOBA -- (MARKET WIRE) -- 11/05/08 -- Gendis Inc. (TSX: GDS) has announced a Normal Course Issuer Bid for a maximum of 714,434 of its Common shares with purchases commencing on January 14, 2008. During the month ended October 31, 2008, Gendis Inc. purchased for cancellation 13,700 of its Common shares for a total consideration of $21,852.87. Total purchases since the Normal Course Issuer Bid commenced up to October 31, 2008 are 192,400 Common shares for a total consideration of $375,208.87.

ADVERTISEMENT
 
Related Quotes
  Last Change % Change
CA;GDS
0.68
0.00 0.00
Contacts:
Gendis Inc.
Mr. James E. Cohen
Executive Vice-President
(204) 474-5200


 
Related News
Dec 09/08 16:50
Gendis Inc. Announces Third Quarter Results (CCN)
Dec 09/08 16:50
Gendis Inc. Announces Third Quarter Results (MRW)
Dec 01/08 15:28
Gendis Inc. Shares Purchased Under Normal Course Issuer Bid (CCN)
Dec 01/08 15:28
Gendis Inc. Shares Purchased Under Normal Course Issuer Bid (MRW)
Nov 05/08 16:12
Gendis Inc. Shares Purchased Under Normal Course Issuer Bid (CCN)

Business News
Jan 06/09 08:19
Fairfax Declares Annual Dividend (MRW)
Jan 06/09 08:19
Fairfax Declares Annual Dividend (CCN)
Jan 06/09 08:15
Fjordland Exploration Inc.: Drilling at Woodjam Advances Three Copper-Gold Zones (CCN)
Jan 06/09 08:15
eSignal Now Offers TSX/CP Equities News (BIZ)
Jan 06/09 08:00
Cytochroma initiates Phase I study of CTAP201 Injection in chronic kidney disease patients (PRN)
Jan 06/09 08:00
SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin (PRN)
Jan 06/09 08:00
Sigma Designs Employs Sidense Memory in IPTV Product (MRW)
Jan 06/09 08:00
FRSGlobal Announces Immediate Availability of Validation and Audit Platform for Advanced Approach to Basel II (MRW)
Jan 06/09 08:00
Clovys TV: The Era of Change Has Come (CCN)
Jan 06/09 08:00
Cytochroma initiates Phase I study of CTAP201 Injection in chronic kidney disease patients (CNW)
 

AlphaTrade.com   |   Advertise   |   Contact Us   |   Disclaimer   |   Legal   |   Privacy
Copyright © 2008 AlphaTrade.com. All rights reserved.
Quotes are delayed 15 minutes.